In melanoma, Hippo signaling is affected by copy number alterations and YAP1 overexpression impairs patient survival
暂无分享,去创建一个
Nora C. Toussaint | O. Kohlbacher | C. Ottmann | S. Perner | K. Ikenberg | C. Busch | C. Garbe | B. Bastian | L. Quintanilla‐Martinez | K. Schilbach | M. Röcken | R. Handgretinger | F. Göke | J. Bauer | M. Menzel | B. Weide | D. Meckbach | T. Eigentler | U. Kohlhofer | Seema Noor | Antonia Göke | S. Noor | J. Bauer
[1] T. Hsieh,et al. 探討Yes-Associated Protein在口腔癌中所扮演的角色 , 2016 .
[2] M. Herlyn,et al. Pro-Invasive Activity of the Hippo Pathway Effectors YAP and TAZ in Cutaneous Melanoma , 2013, The Journal of investigative dermatology.
[3] Gerald C. Chu,et al. Proinvasion metastasis drivers in early-stage melanoma are oncogenes. , 2011, Cancer cell.
[4] Jun Yu,et al. Yes-Associated Protein 1 Exhibits Oncogenic Property in Gastric Cancer and Its Nuclear Accumulation Associates with Poor Prognosis , 2011, Clinical Cancer Research.
[5] H. Pasolli,et al. Yes-associated protein (YAP) transcriptional coactivator functions in balancing growth and differentiation in skin , 2011, Proceedings of the National Academy of Sciences.
[6] S. Hilsenbeck,et al. Hippo pathway effector Yap is an ovarian cancer oncogene. , 2010, Cancer research.
[7] D. Pan,et al. The hippo signaling pathway in development and cancer. , 2010, Developmental cell.
[8] R. Jaenisch,et al. YAP1 Increases Organ Size and Expands Undifferentiated Progenitor Cells , 2007, Current Biology.
[9] G. Feldmann,et al. Elucidation of a Universal Size-Control Mechanism in Drosophila and Mammals , 2007, Cell.
[10] B. Edgar,et al. Filling out the Hippo pathway , 2007, Nature Reviews Molecular Cell Biology.
[11] M. Wigler,et al. Identification and Validation of Oncogenes in Liver Cancer Using an Integrative Oncogenomic Approach , 2006, Cell.
[12] Jean-Philippe Brunet,et al. The melanocyte differentiation program predisposes to metastasis after neoplastic transformation , 2005, Nature Genetics.